Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2020 | Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study | ANNALS OF ONCOLOGY |